News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,525 Results
Type
Article (15095)
Company Profile (299)
Press Release (276125)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (81465)
Career Advice (169)
Deals (13805)
Drug Delivery (41)
Drug Development (52364)
Employer Resources (31)
FDA (6357)
Job Trends (5542)
News (149557)
Policy (10602)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (941)
Accelerated approval (20)
Adcomms (14)
Allergies (86)
Alliances (22102)
ALS (127)
Alzheimer's disease (1074)
Antibody-drug conjugate (ADC) (261)
Approvals (6612)
Artificial intelligence (270)
Autoimmune disease (119)
Automation (9)
Bankruptcy (106)
Best Places to Work (4962)
BIOSECURE Act (6)
Biosimilars (106)
Biotechnology (230)
Bladder cancer (113)
Brain cancer (46)
Breast cancer (411)
Cancer (3374)
Cardiovascular disease (265)
Career advice (153)
Career pathing (7)
CAR-T (223)
CDC (5)
Cell therapy (575)
Cervical cancer (17)
Clinical research (45439)
Collaboration (1187)
Company closure (2)
Compensation (609)
Complete response letters (41)
COVID-19 (1127)
CRISPR (86)
C-suite (566)
Cystic fibrosis (114)
Data (4639)
Denatured (15)
Depression (94)
Diabetes (273)
Diagnostics (1506)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (196)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (32650)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (53096)
Executive appointments (633)
FDA (8273)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1005)
Gene editing (182)
Generative AI (22)
Gene therapy (500)
GLP-1 (519)
Government (1213)
Grass and pollen (3)
Guidances (175)
Healthcare (6891)
HIV (25)
Huntington's disease (43)
IgA nephropathy (76)
Immunology and inflammation (195)
Immuno-oncology (43)
Indications (76)
Infectious disease (1243)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (43)
Intellectual property (168)
Interviews (19)
IPO (7673)
IRA (13)
Job creations (890)
Job search strategy (133)
JPM (41)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (9)
Legal (1450)
Liver cancer (47)
Longevity (12)
Lung cancer (465)
Lymphoma (269)
Machine learning (26)
Management (7)
Manufacturing (385)
MASH (132)
Medical device (2924)
Medtech (2933)
Mergers & acquisitions (6773)
Metabolic disorders (756)
Multiple sclerosis (111)
NASH (13)
Neurodegenerative disease (245)
Neuropsychiatric disorders (72)
Neuroscience (2024)
Neurotech (1)
NextGen: Class of 2026 (2106)
Non-profit (974)
Now hiring (30)
Obesity (340)
Opinion (126)
Ovarian cancer (137)
Pain (107)
Pancreatic cancer (171)
Parkinson's disease (235)
Partnered (13)
Patents (308)
Patient recruitment (343)
Peanut (43)
People (26998)
Pharmaceutical (44)
Pharmacy benefit managers (7)
Phase 1 (15682)
Phase 2 (20767)
Phase 3 (13858)
Pipeline (3480)
Policy (91)
Postmarket research (1004)
Preclinical (6591)
Press Release (35)
Prostate cancer (158)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (662)
Real estate (1475)
Recruiting (12)
Regulatory (10504)
Reports (19)
Research institute (1005)
Resumes & cover letters (21)
Rett syndrome (24)
RNA editing (21)
RSV (20)
Schizophrenia (127)
Series A (185)
Series B (141)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (18)
Startups (2010)
State (1)
Stomach cancer (6)
Supply chain (33)
Tariffs (19)
The Weekly (62)
Vaccines (359)
Venture capital (69)
Weight loss (178)
Women's health (27)
Worklife (2)
Date
Today (80)
Last 7 days (372)
Last 30 days (1299)
Last 365 days (18645)
2026 (1856)
2025 (18885)
2024 (21216)
2023 (23128)
2022 (27582)
2021 (28757)
2020 (24241)
2019 (16930)
2018 (12356)
2017 (14273)
2016 (12303)
2015 (14844)
2014 (10723)
2013 (7730)
2012 (7764)
2011 (7880)
2010 (7634)
Location
Africa (159)
Alabama (66)
Alaska (2)
Arizona (73)
Arkansas (5)
Asia (18647)
Australia (3172)
California (7209)
Canada (1912)
China (791)
Colorado (256)
Connecticut (272)
Delaware (269)
Europe (40696)
Florida (918)
Georgia (220)
Hawaii (3)
Idaho (17)
Illinois (411)
India (38)
Indiana (194)
Iowa (8)
Japan (278)
Kansas (81)
Kentucky (10)
Louisiana (8)
Maine (12)
Maryland (745)
Massachusetts (5698)
Michigan (112)
Minnesota (256)
Mississippi (3)
Missouri (42)
Montana (16)
Nebraska (5)
Nevada (41)
New Hampshire (21)
New Jersey (2050)
New Mexico (13)
New York (1818)
North Carolina (884)
North Dakota (6)
Northern California (3551)
Ohio (185)
Oklahoma (11)
Oregon (24)
Pennsylvania (1319)
Puerto Rico (9)
Rhode Island (25)
South America (225)
South Carolina (9)
Southern California (2855)
Tennessee (44)
Texas (941)
United States (24377)
Utah (100)
Virginia (138)
Washington D.C. (39)
Washington State (611)
West Virginia (1)
Wisconsin (52)
291,525 Results for "c3j therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
·
3 min read
Press Releases
Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
January 13, 2026
·
9 min read
Press Releases
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
January 22, 2026
·
4 min read
Press Releases
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
2 min read
Press Releases
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
February 5, 2026
·
5 min read
Press Releases
Travere Therapeutics Provides Corporate Update and 2026 Outlook
January 13, 2026
·
17 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
·
8 min read
Press Releases
Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity
January 26, 2026
·
3 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
1 of 29,153
Next
